GRUPO 5

Cardiac arrest and

atrioventricular block (AVB)
for pacemaker passage

Shock mainly in

distributive origin or associated

with low peripheral vascular
resistance
Cardiac decompensation caused by
congestive heart failure, cardiogenic
shock or after cardiac surgery
Heart rate control in atrial
fibrillation, especially associated
Decreases peripheral systemic
with heart failure
vascular resistance
Correction of hemodynamic imbalances
that occur in shock syndrome due to
myocardial infarction, trauma, endotoxic
septicemia, open heart surgery and Operative hypotension
decompensation. and septic shock

ADRENALIN
It is used in NOREPINEPHRINE
DARUSETAN ISOPROTERENOL
hypertension

DIGOXIN
FRENILEFIN
DOPAMINE DOBUTAMINE

ANTAGONISTS

Lowers pulmonary arterial

pressure (PAP) and provides a
positive inotropic effect

Heart transplant, cx
SITAXSENTAN
mitral valve

INOTROPIC
MILRINONE
DRUGS

Coronary and systemic PHARMACOLOGY Improves cardiac output due to inotropic

Calcium Sensitizing PHOSPHODIESTERASE
vasodilation, cardiac LEVOSIMENDA OTHER DRUGS IN effect and reduction of systemic vascular
Agents INHIBITORS
contractility CARDIOVACULAR resistance without increased heart rate

Heart failure patients CADOTRIL

E
ENDOPEPTIDASE
INHIBITORS

VASODILATORS
GRUPO 5:

TREATMENT OF
CANDOXATRIL
INSUFFICIENCY
Consuelo Cárdenas

Dayanna de León

Wendy Rios

Cristian Ardila

Valeria Gualdrón

Marlyn Turizo
BETA BLOCKER
NITROPUSIATO DE SODIO ENZYME INHIBITORS DIURETICS
Laura Álvares
NITROGLYCERINE CALCIUM ANTAGONIST
Valentina Garcia

It is recommended for patients with

M yocardial infarction,
congestive left ventricular
failure, arterial hypertension
crisis during surgical
procedures.
Coronary vasodilation, Hypertensive emergencies, congestive heart failure educes swelling coronary artery disease or high
tachycardia intraoperative controlled
R
cardiac risk, cardiac pathologies.
hypotension